Low Sero-prevalence of Hepatitis Delta Antibodies in HIV/ Hepatitis B Co-infected Patients Attending an Urban HIV Clinic in Uganda

Overview

Journal Afr Health Sci

Date 2017 May 9

PMID 28479902

Citations 4

Authors

Elizabeth Katwesigye

Emmanuel Seremba

Fred Semitala

Ponsiano Ocama

Affiliations

Soon will be listed here.

Abstract

Background: Co-infection with hepatitis B (HBV) and hepatitis D (HDV) is common among human immunodeficiency virus (HIV) infected individuals in developing countries and it aggressively accelerates progression of liver disease to cirrhosis and other complications. There is scarcity of data on HDV in sub-Saharan Africa .We investigated the sero-prevalence and factors associated with HDV antibody among HIV/HBV co-infected patients attending a large urban HIV clinic in Uganda.

Methods: We screened 189 HIV/HBV co-infected individuals for anti-HDV immunoglobulin G (IgG) and performed logistic regression to determine the associated factors. Socio-demographic, clinical data, immunological status, and liver fibrosis (as determined by the Aspartate transaminase to platelet ratio index and transient elastography) were included.

Results: Participants were predominately young and of sound immunologic status (median age 40 years, median CD4 440 cells/µl). 98% were on ART regimens containing anti-HBV active medications (95.2% were on TDF/3TC while 4.8% on 3TC containing regimen). Median duration on ART was 36 months (IQR 22-72). Anti-HDV was detected in 6/198, 3.2% (95% CI 1.14-6.92%), associated with male gender and a duration of more than 5 years since HIV diagnosis.

Conclusions: The sero-prevalence of HDV antibodies among the HIV/HBV co-infected patients is low in a Ugandan urban cohort.

Citing Articles

Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria.

Opaleye O, Akanbi O, Osundare F, Wang B, Adesina O, Oluremi A Virol J. 2021; 18(1):20.

PMID: 33446224 PMC: 7809746. DOI: 10.1186/s12985-021-01493-4.

Capacity assessment for provision of quality sexual reproductive health and HIV-integrated services in Karamoja, Uganda.

Marotta C, Lochoro P, Pizzol D, Putoto G, Mazzucco W, Saracino A Afr Health Sci. 2021; 20(3):1053-1065.

PMID: 33402951 PMC: 7751512. DOI: 10.4314/ahs.v20i3.8.

Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Ferrante N, Lo Re 3rd V Curr HIV/AIDS Rep. 2020; 17(4):405-414.

PMID: 32607773 PMC: 7571375. DOI: 10.1007/s11904-020-00508-z.

Child, reproductive, mental health; infections and NCDs in the African environment.

Tumwine J Afr Health Sci. 2017; 16(4):i-iii.

PMID: 28479915 PMC: 5398469. DOI: 10.4314/ahs.v16i4.1.

References

Onyekwere C, Audu R, Duro-Emmanuel F, Ige F . Hepatitis D infection in Nigeria. Indian J Gastroenterol. 2012; 31(1):34-5. DOI: 10.1007/s12664-011-0158-9. View

Fernandez-Montero J, Vispo E, Barreiro P, Sierra-Enguita R, de Mendoza C, Labarga P . Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Clin Infect Dis. 2014; 58(11):1549-53. DOI: 10.1093/cid/ciu167. View

Lunel-Fabiani F, Mansour W, Amar A, Aye M, Le Gal F, Malick F . Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study. J Infect. 2013; 67(5):448-57. DOI: 10.1016/j.jinf.2013.06.008. View

Rizzetto M, Ciancio A . Epidemiology of hepatitis D. Semin Liver Dis. 2012; 32(3):211-9. DOI: 10.1055/s-0032-1323626. View

Winter A, Letang E, Kalinjuma A, Kimera N, Ntamatungiro A, Glass T . Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania. Int J Infect Dis. 2016; 46:8-10. DOI: 10.1016/j.ijid.2016.03.011. View

Palella Jr F, Baker R, Moorman A, Chmiel J, Wood K, Brooks J . Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006; 43(1):27-34. DOI: 10.1097/01.qai.0000233310.90484.16. View

Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina J . Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. J Viral Hepat. 2009; 17(1):65-76. DOI: 10.1111/j.1365-2893.2009.01153.x. View

Soriano V, Vispo E, Sierra-Enguita R, de Mendoza C, Fernandez-Montero J, Labarga P . Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients. AIDS. 2014; 28(16):2389-94. DOI: 10.1097/QAD.0000000000000417. View

Serrano B, Manns M, Wedemeyer H . Hepatitis delta and HIV infection. Semin Liver Dis. 2012; 32(2):120-9. DOI: 10.1055/s-0032-1316467. View

10.

Hughes S, Wedemeyer H, Harrison P . Hepatitis delta virus. Lancet. 2011; 378(9785):73-85. DOI: 10.1016/S0140-6736(10)61931-9. View

11.

Niro G, Ciancio A, Tillman H, Lagget M, Olivero A, Perri F . Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther. 2005; 22(3):227-32. DOI: 10.1111/j.1365-2036.2005.02542.x. View

12.

Tahaei S, Mohebbi S, Azimzadeh P, Behelgardi A, Sanati A, Mohammadi P . Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani hospital, Tehran, Iran. Gastroenterol Hepatol Bed Bench. 2014; 7(3):144-50. PMC: 4129564. View

13.

Shaikh M, Shaikh W, Solangi G, Shaikh B, Soomro M . Frequency of hepatitis D virus infection in hepatitis B surface antigen-positive liver diseases. J Coll Physicians Surg Pak. 2011; 21(1):23-5. DOI: 01.2011/JCPSP.2325. View

14.

Liaw Y, Chiu K, Chu C, Sheen I, Huang M . Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. J Infect Dis. 1990; 162(5):1170-2. DOI: 10.1093/infdis/162.5.1170. View

15.

Wedemeyer H, Manns M . Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010; 7(1):31-40. DOI: 10.1038/nrgastro.2009.205. View

16.

Hung C, Wu S, Lin P, Sheng W, Yang Z, Sun H . Increasing incidence of recent hepatitis D virus infection in HIV-infected patients in an area hyperendemic for hepatitis B virus infection. Clin Infect Dis. 2014; 58(11):1625-33. PMC: 4072904. DOI: 10.1093/cid/ciu127. View

17.

Cunha L, Plouzeau C, Ingrand P, Gudo J, Ingrand I, Mondlane J . Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol. 2007; 79(12):1832-40. DOI: 10.1002/jmv.21010. View

18.

Diop-Ndiaye H, Toure-Kane C, Etard J, Lo G, Diaw P, Ngom-Gueye N . Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol. 2008; 80(8):1332-6. DOI: 10.1002/jmv.21236. View

19.

Soriano V, Grint D, Monforte A, Horban A, Leen C, Poveda E . Hepatitis delta in HIV-infected individuals in Europe. AIDS. 2011; 25(16):1987-92. DOI: 10.1097/QAD.0b013e32834babb3. View

20.

Andernach I, Leiss L, Tarnagda Z, Tahita M, Otegbayo J, Forbi J . Characterization of hepatitis delta virus in sub-Saharan Africa. J Clin Microbiol. 2014; 52(5):1629-36. PMC: 3993620. DOI: 10.1128/JCM.02297-13. View